Skip to content

Real Word Study on Myopia Control With Repeated Red Light Therapy for Ages of 3~6 Years Old

Random、Control and Open Study of Real Word Study on Myopia Control With Repeated Red Light Therapy for Ages of 3~6 Years Old

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05811598
Acronym
RMC
Enrollment
60
Registered
2023-04-13
Start date
2023-03-21
Completion date
2024-12-30
Last updated
2023-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amblyopia, Myopia

Keywords

Myopia, Children, LLLT, PBM

Brief summary

Repeated Red Light Therapy had been used as an amblyopia therapy for children as well as the myopia control in primary schools. However, ultra low lever of red light therapy with irradiance of 0.37mW and 0.60mW effectiveness and safety for 3\ 6 year-old myopia treatment or slow myopia progression are seldom reported.

Detailed description

Repeated Red Light Therapy had been used as an amblyopia therapy for children as well as the myopia control in primary schools. However, ultra low lever of red light therapy with irradiance of 0.37mW and 0.60mW effectiveness and safety for 3\ 6 year-old myopia treatment or slow myopia progression are seldom reported. Here we design this control and random prospective study to find the two types light with different irridance to two ages (3\ 4 years old and 5\ 6 years old) respectively. Wether the dose and effectiveness exit or not for 3\ 6- year- old myopia control.

Interventions

DEVICErepeated ultra low lever red light

Myopia indoor lighting therapy

Sponsors

Beijing Airdoc Technology Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

two groups for the 2 lighting lever (0.37mW and 0.6mW)for 2 groups of ages (3\ 4 years old and 5\ 6 years old)

Eligibility

Sex/Gender
ALL
Age
3 Years to 6 Years
Healthy volunteers
No

Inclusion criteria

* 3\ 6 years old; * Myopia Spherical Equivalence Refraction \<=-0.50D; * Written Informed Consent;

Exclusion criteria

* Cannot approval with written informed consent; * Photophobia or allergy to red light; * With other severe conditions the principle investigators refused to enroll this study

Design outcomes

Primary

MeasureTime frameDescription
Mean changes of axial length vaules by millimeter at follow-up from baseline.at 3-month and at 6-monthOcular axial length measured by IOLmaster500 or Lenstar will be measured and recorded at follow-ups and at baseline. The changes values of axial length of both groups will be compared as the main outcome to compare the effectiveness of repeated red light thearpy.

Secondary

MeasureTime frameDescription
Numbers of children without myopic refraction changes by spherical equivalence values from refraction at follow-up from baseline(D)at 3-month and at 6-monthCycloplegic refraction changes from baseline will be measured and recorded at follow-up and at baseline. Spherical equivalence will be calculated with the formular of SE=spherical diopter+1/2cylinder diopter
Number of Participants with unsafety issues during the studyat 6-monthAdverse event and device failure rate

Other

MeasureTime frameDescription
Rate of subjects meet with repeated red light thearpy greater than 85% of the specified requirementsfrequence recordat 1-month, 3-month and 6-monthTwice daily with an interval of 4 hours or mor, and 3 minutes at each session

Countries

China

Contacts

Primary ContactWensi Shen, MD,PhD
369353779@QQ.COM+8613631318044
Backup ContactJenny Qiu, MD
qiukaikai0620@airdoc.com+8618510386815

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026